SEC Info - Kintara Therapeutics, Inc. - ‘8-K’ for 8/2/22

SEC Info℠

Home

Help

Please Sign In

Kintara Therapeutics, Inc. – ‘8-K’ for 8/2/22 – ‘EX-101.SCH’

On: Wednesday, 8/3/22, at 4:06pm ET · For: 8/2/22 · Accession #: 950170-22-14228 · File #: 1-37823

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/22  Kintara Therapeutics, Inc.        8-K:1,8,9   8/02/22   14:1M                                     Donnelley … Solutions/FA

Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     97K 
 2: EX-5.1      Opinion of Counsel re: Legality                     HTML     24K 
 3: EX-10.1     Material Contract                                   HTML    524K 
 4: EX-10.2     Material Contract                                   HTML    171K 
 5: EX-99.1     Miscellaneous Exhibit                               HTML     22K 
 9: R1          Document and Entity Information                     HTML     48K 
12: XML         IDEA XML File -- Filing Summary                      XML     13K 
10: XML         XBRL Instance -- ktra-20220802_htm                   XML     16K 
11: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 8: EX-101.LAB  XBRL Labels -- ktra-20220802_lab                     XML     56K 
 6: EX-101.PRE  XBRL Presentations -- ktra-20220802_pre              XML     36K 
 7: EX-101.SCH  XBRL Schema -- ktra-20220802                         XSD     12K 
13: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    20K 
14: ZIP         XBRL Zipped Folder -- 0000950170-22-014228-xbrl      Zip    118K

‘EX-101.SCH’ — XBRL Schema — ktra-20220802

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema targetNamespace="http://www.kintara.com/20220802" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ktra="http://www.kintara.com/20220802" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>

<xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>

<xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>

<xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022"/>

<xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ktra-20220802_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ktra-20220802_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>

<link:roleType roleURI="http://www.kintara.com/20220802/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">

<link:definition> 100000 - Document - Document and Entity Information </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>

<link:usedOn> link:calculationLink </link:usedOn>

<link:usedOn> link:definitionLink </link:usedOn>

</link:roleType>

</xsd:appinfo>

</xsd:annotation>

</xsd:schema>

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/27/23  Kintara Therapeutics, Inc.        S-1/A                 12:1.2M                                   Donnelley … Solutions/FA
10/24/23  Kintara Therapeutics, Inc.        S-1/A                 20:2.4M                                   Donnelley … Solutions/FA
10/04/23  Kintara Therapeutics, Inc.        S-1                   13:1.1M                                   Donnelley … Solutions/FA
 9/18/23  Kintara Therapeutics, Inc.        10-K        6/30/23   75:12M                                    Donnelley … Solutions/FA
11/09/22  Kintara Therapeutics, Inc.        10-Q        9/30/22   58:8.8M                                   Donnelley … Solutions/FA
 9/27/22  Kintara Therapeutics, Inc.        S-8         9/27/22    4:271K                                   Donnelley … Solutions/FA
 9/27/22  Kintara Therapeutics, Inc.        10-K        6/30/22   79:15M                                    Donnelley … Solutions/FA

↑Top